$BODI Cashflow Statement | Understand Stock

$BODI

$4.01 -$0.16 (3.84%) Close

$BODI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment of goodwill and intangible assets
Impairment of intangible assets
Impairment of other investments
Depreciation and amortization expense
Amortization of content assets
Provision for inventory
Realized losses on hedging derivative financial instruments
Gain on investment in convertible instrument
Change in fair value of warrant liabilities
Gain on lease assignment
Equity-based compensation
Deferred income taxes
Amortization of debt issuance costs
Paid-in-kind interest expense
Loss on debt extinguishment
Change in lease assets
Gain on sale of property and equipment
Other non-cash items
Changes in operating assets and liabilities:
Inventory
Content assets
Prepaid expenses
Other assets
Accounts payable
Accrued expenses
Deferred revenue
Other liabilities

Net cash provided by operating activities

Cash flows from investing activities:
Purchase of property and equipment
Investment in convertible instrument
Other investment
Cash paid for acquisition, net of cash acquired
Investment in restricted short-term investments
Proceeds from sale of property and equipment
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Proceeds from exercise of stock options
Remittance of taxes withheld from employee stock awards
Debt Borrowings
Debt repayments
Business combination, net of issuance costs paid
Shares withheld for tax withholdings on vesting of restricted stock
Proceeds from issuance of common shares in the Employee Stock Purchase Plan
Tax withholdings payments for vesting of restricted stock
Payment of debt issuance costs
Proceeds from issuance of Equity Offering, net of issuance costs
Net cash provided by (used in) financing activities

Effect of exchange rates on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Supplemental disclosure of cash flow information:
Cash paid during the year for interest
Cash paid during the year for income taxes, net
Cash received during the year for federal income taxes
Cash paid during the year for Texas GMT income taxes
Cash paid during the year
UNITED KINGDOM
CANADA
Other jurisdictions
Supplemental disclosure of noncash investing activities:
Property and equipment acquired but not yet paid for
Common shares issued in connection with acquisition

Supplemental disclosure of noncash financing activities:
Warrants issued in relation to Term Loan
Change in fair value of term loan warrants due to amended exercise price
Paid-in-kind fee recorded as incremental debt issuance cost

Comments